Vonkeman HE - Search Results

1

Understanding the NSAID related risk of vascular events.

Vonkeman HE, Brouwers JR, van de Laar MA. Vonkeman HE, et al. BMJ. 2006 Apr 15;332(7546):895-8. doi: 10.1136/bmj.332.7546.895. BMJ. 2006. PMID: 16613964 Free PMC article. Review. No abstract available.

2

[Fatal miliary tuberculosis during treatment with infliximab].

Vonkeman HE, van der Valk PD, Mulder L, van de Laar MA. Vonkeman HE, et al. Ned Tijdschr Geneeskd. 2002 Jun 22;146(25):1196-9. Ned Tijdschr Geneeskd. 2002. PMID: 12109312 Dutch.

3

Disseminated primary varicella infection during infliximab treatment.

Vonkeman H, ten Napel C, Rasker H, van de Laar M. Vonkeman H, et al. J Rheumatol. 2004 Dec;31(12):2517-8. J Rheumatol. 2004. PMID: 15570661

4

Allele variants of the cytochrome P450 2C9 genotype in white subjects from The Netherlands with serious gastroduodenal ulcers attributable to the use of NSAIDs.

Vonkeman HE, van de Laar MA, van der Palen J, Brouwers JR, Vermes I. Vonkeman HE, et al. Clin Ther. 2006 Oct;28(10):1670-6. doi: 10.1016/j.clinthera.2006.10.019. Clin Ther. 2006. PMID: 17157122

5

Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.

Vonkeman HE, Fernandes RW, van der Palen J, van Roon EN, van de Laar MA. Vonkeman HE, et al. Arthritis Res Ther. 2007;9(3):R52. doi: 10.1186/ar2207. Arthritis Res Ther. 2007. PMID: 17521422 Free PMC article.

6

Under-utilization of gastroprotective drugs in patients with NSAID-related ulcers.

Vonkeman HE, Fernandes RW, van de Laar MA. Vonkeman HE, et al. Int J Clin Pharmacol Ther. 2007 May;45(5):281-8. doi: 10.5414/cpp45281. Int J Clin Pharmacol Ther. 2007. PMID: 17542350

7

Direct medical costs of serious gastrointestinal ulcers among users of NSAIDs.

Vonkeman HE, Klok RM, Postma MJ, Brouwers JR, van de Laar MA. Vonkeman HE, et al. Drugs Aging. 2007;24(8):681-90. doi: 10.2165/00002512-200724080-00005. Drugs Aging. 2007. PMID: 17702536

8

Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.

de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, van Tulder MW, Kuipers EJ, Boers M, Dijkmans BA. de Leest HT, et al. Among authors: vonkeman he. Helicobacter. 2007 Oct;12(5):477-85. doi: 10.1111/j.1523-5378.2007.00543.x. Helicobacter. 2007. PMID: 17760715 Clinical Trial.

9

Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention.

Vonkeman HE, van de Laar MA. Vonkeman HE, et al. Semin Arthritis Rheum. 2010 Feb;39(4):294-312. doi: 10.1016/j.semarthrit.2008.08.001. Epub 2008 Sep 27. Semin Arthritis Rheum. 2010. PMID: 18823646 Review.

10

Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.

Vonkeman HE, Braakman-Jansen LM, Klok RM, Postma MJ, Brouwers JR, van de Laar MA. Vonkeman HE, et al. Arthritis Res Ther. 2008;10(6):R144. doi: 10.1186/ar2577. Epub 2008 Dec 16. Arthritis Res Ther. 2008. PMID: 19077318 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page